Roivant Sciences (ROIV) Prepaid Assets (2021 - 2026)
Roivant Sciences (ROIV) reported Prepaid Assets of $105.3 million for Q1 2026, down 6.94% on a YoY basis from $113.2 million in Q1 2025, and down 18.93% quarter-over-quarter from $129.9 million in Q4 2025.
Roivant Sciences (ROIV) Prepaid Assets (2021 - 2026) Analysis & Trends
Roivant Sciences has reported Prepaid Assets for 6 years, with the latest figure at $105.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 6.94% year-over-year to $105.3 million; the trailing twelve-month figure through Mar 2026 stood at $105.3 million (down 6.94% YoY), and the FY2026 full-year result was $105.3 million, down 6.94% from the prior year.
- Prepaid Assets for Q1 2026 stood at $105.3 million, down from $129.9 million in the prior quarter.
- The five-year high for Prepaid Assets was $129.9 million in Q4 2025, with the low at $52.6 million in Q4 2023.
- Historically, Prepaid Assets has averaged $87.3 million across 5 years, with a median of $86.1 million in 2022.
- Annual changes were most pronounced in 2023 — Prepaid Assets slumped 55.69% — and 2025, when it jumped 125.32%.
- Roivant Sciences' Prepaid Assets stood at $118.8 million in 2022, then tumbled by 55.69% to $52.6 million in 2023, then climbed by 9.53% to $57.7 million in 2024, then jumped by 125.32% to $129.9 million in 2025, then decreased by 18.93% to $105.3 million in 2026.
- The last three Prepaid Assets figures came in at $105.3 million (Q1 2026), $129.9 million (Q4 2025), and $125.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.32 Mn |
| Dec 31, 2025 | 129.91 Mn |
| Sep 30, 2025 | 125.81 Mn |
| Jun 30, 2025 | 112.60 Mn |
| Mar 31, 2025 | 113.17 Mn |
| Dec 31, 2024 | 57.66 Mn |
| Sep 30, 2024 | 94.23 Mn |
| Jun 30, 2024 | 57.28 Mn |
| Mar 31, 2024 | 80.61 Mn |
| Dec 31, 2023 | 52.64 Mn |
| Sep 30, 2023 | 60.72 Mn |
| Jun 30, 2023 | 64.66 Mn |
| Mar 31, 2023 | 60.83 Mn |
| Dec 31, 2022 | 118.80 Mn |
| Sep 30, 2022 | 70.30 Mn |
| Jun 30, 2022 | 93.27 Mn |
| Mar 31, 2022 | 86.12 Mn |
| Dec 31, 2021 | 70.33 Mn |
| Sep 30, 2021 | 55.56 Mn |
| Jun 30, 2021 | 58.17 Mn |